Clinical Trial Update: Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluates finerenone in patients with primary aldosteronism. The study has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Chongqing Medical University | Conditions: Primary Aldosteronism | Phase 4 | Status: COMPLETED